Chapter 25.5
Recurrent Disease and Management in Liver Transplantation
Xavier Forns,
Antoni Rimola,
Xavier Forns
Search for more papers by this authorAntoni Rimola
Search for more papers by this authorXavier Forns,
Antoni Rimola,
Xavier Forns
Search for more papers by this authorAntoni Rimola
Search for more papers by this authorBook Editor(s):Juan Rodés MD,
Jean-Pierre Benhamou MD,
Andres T. Blei MD,
Jürg Reichen MD,
Mario Rizzetto MD,
Juan Rodés MD
Director General, Hospital Clinic; Professor of Medicine, University of Barcelona, Barcelona, Spain
Search for more papers by this authorJean-Pierre Benhamou MD
Professor of Hepatology, Université Denis Diderot Paris 7, Assistance Publique — Hôpitaux de Paris and Inserm U773, Service d'Hépatologie, Hôpital Beaujon, Clichy, France
Search for more papers by this authorAndres T. Blei MD
Professor of Medicine and Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
Search for more papers by this authorJürg Reichen MD
Professor of Medicine, University of Bern; Chief of Hepatology, University Hospital, Bern, Switzerland
Search for more papers by this authorMario Rizzetto MD
Professor of Gastroenterology, University of Turin, Turin, Italy
Search for more papers by this authorFirst published: 18 June 2007
References
- Villamil FG (2002) Hepatitis B: progress in the last 15 years. Liver Transpl 8, S59–S66.
- Samuel D, Muller R, Alexander G et al. (1993) Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 329, 1842–1847.
- Lok ASF (2002) Prevention of recurrent hepatitis B post-liver transplantation. Liver Transpl 8, S67–S73.
- Terrault N, Roche B, Samuel D (2005) Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective. Liver Transpl 11, 716–732.
- Villeneuve JP, Condreay LD, Willems B et al. (2000) Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology 31, 207–210.
- Perrillo RP, Wright T, Rakela J et al. (2001) A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B. Hepatology 33, 424–432.
- Schiff ER, Lai CL, Hadziyannis S et al. (2003) Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patient. Hepatology 38, 1419–1427.
- Samuel D, Bismuth A, Mathieu D et al. (1991) Passive immunopro-phylaxis after liver transplantation in HBsAg-positive patients. Lancet 337, 813–815.
- Ghany MG, Ayola B, Villamil, FG et al. (1998) Hepatitis B S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 27, 213–222.
- Buti M, Mas A, Prieto M et al. (2003) A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIG) and lamivudine with long-term lamivudine plus HBIG in the prevention of hepatitis B recurrence after liver transplantation. J Hepatol 38 (6), 811–817.
- García-Retortillo, M, Forns X, Feliu, A et al. (2002) Hepatitis C virus kinetics during and immediately after liver transplantation. Hepatology 35, 680–687.
- Prieto M, Berenguer M, Rayon, JM et al. (1999) High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology 29, 250–256.
- Garcia-Retortillo, M, Forns X, Llovet, JM et al. (2004) Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. Hepatology 40, 699–707.
- Berenguer M, Prieto M, Rayón, JM et al. (2000) Natural history of clinically compensated HCV related graft cirrhosis following liver transplantation. Hepatology 32, 852–858.
- Forman LM, Lewis JD, Berlin JA et al. (2002) The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 122, 889–896.
- Wiesner RH, Sorrell M, Villamil F and the International Liver Transplantation Society Expert Panel (2003) Report of the first International Liver Transplantation Society panel consensus conference on liver transplantation and hepatitis C. Liver Transpl 9 (Suppl. 3), S1–S9.
- Berenguer M, Prieto M, San Juan F et al. (2002) Contribution of donor age to the recent decrease in patients survival among HCV-infected liver transplant recipients. Hepatology 36, 202–210.
- Shiffman ML, Stravitz RT, Contos MJ et al. (2004) Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Liver Transpl 10, 1248–1255.
- Garcia-Retortillo, M, Forns, X (2004) Prevention and treatment of hepatitis C virus recurrence after liver transplantation. J Hepatol 41, 2–10.
- Everson GT, Trotter J, Forman L et al. (2005) Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology 42, 255–262.
- Forns X, García-Retortillo, M, Serrano, T et al. (2003) Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation. J Hepatol 39, 389–396.
- Chalasani N, Manzarbeitia C, Ferenci P et al. (2005) Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials. Hepatology 41, 289–298.
- Neumann UP, Berg T, Bahra M et al. (2004) Fibrosis progression after liver transplantation in patients with recurrent hepatitis C. J Hepatol 41, 830–836.
- Samuel D, Bizollon T, Feray C et al. (2003) Interferon alfa-2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. Gastroenterology 124, 642–650.
- Neuberger J (2003) Recurrent primary biliary cirrhosis. Liver Transpl 9, 539–546.
- Graziadei I (2002) Recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 8, 575–581.
- Manns MP, Bahr MJ (2000) Recurrent autoimmune hepatitis after liver transplantation-when non-self becomes self. Hepatology 32, 868–869.
- Guy JE, Qian P, Lowell JA et al. (2005) Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant. Liver Transpl 11, 1252–1257.
- Luettig B, Boeker KH, Schoessler W et al. (1998) The antinuclear autoantibodies SP100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis. J Hepatol 28, 824–828.
- Knoop M, Bechstein WO, Schrem H et al. (1996) Clinical significance of recurrent primary biliary cirrhosis after liver transplantation. Transpl Int 9 (Suppl. 1), S115–119.
- Renz JF, Ascher NL (2002) Liver transplantation for nonviral, non-malignant diseases: problem of recurrence. World J Surg 26, 247–256.
- Khettry U, Anand N, Faul PN et al. (2003) Liver transplantation for primary biliary cirrhosis: a long-term pathologic study. Liver Transpl 9, 87–96.
- Sylvestre PB, Batts KP, Burgart LJ et al. (2003) Recurrence of primary biliary cirrhosis after liver transplantation: histologic estimate of incidence and natural history. Liver Transpl 9, 1086–1093.
- Sanchez EQ, Levy MF, Goldstein RM et al. (2003) The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation. Transplantation 76, 1583–1588.
- Neuberger J, Gunson B, Hubscher S et al. (2004) Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl 10, 488–491.
- Sebagh M, Farges O, Dubel L et al. (1998) Histological features predictive of recurrence of primary biliary cirrhosis after liver transplantation. Transplantation 65, 1328–1333.
- Demetris AJ, Markus BH, Esquivel C et al. (1988) Pathologic analysis of liver transplantation for primary biliary cirrhosis. Hepatology 8, 939–947.
- Van de Water J, Gerson LB, Ferrell, LD et al. (1996) Immuno-histochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. Hepatology 24, 1079–1084.
- Sheng R, Zajko AB, Campbell WL et al. (1993) Biliary strictures in hepatic transplants: prevalence and types in patients with primary sclerosing cholangitis vs those with other liver diseases. Am J Roentgenol 161, 297–300.
- Guichelaar MMJ, Benson JT, Malinchoc M et al. (2003) Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation. Am J Transpl 3, 885–890.
- McEntee G, Wiesner RH, Rosen C et al. (1991) A comparative study of patients undergoing liver transplantation for primary sclerosing cholangitis and primary biliary cirrhosis. Transpl Proc 23, 1563–1564.
- Graziadei IW, Wiesner RH, Batts KP et al. (1999) Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology 29, 1050–1056.
- Vera A, Moledina S, Gunson B et al. (2002) Risk factors for recurrence of primary sclerosing cholangitis of liver allograft. Lancet 360, 1943–1944.
- Kugelmas M, Spiegelman P, Osgood MJ et al. (2003) Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 9, 727–732.
- Khettry U, Keaveny A, Goldar-Najafi, A et al. (2003) Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathol-ogical study. Hum Pathol 34, 1127–1136.
- Bransaeter B, Schrumpf E, Bentdal O et al. (2005) Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors. Liver Transpl 11, 1361–1369.
- Jeyarajah DR, Netto GJ, Lee SP et al. (1988) Recurrent primary sclerosing cholangitis after orthotopic liver transplantation. Is chronic rejection part of the disease process' Hepatology 66, 1300–1306.
- Goss JA, Shackleton CR, Farmer DG et al. (1997) Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg 225, 472–483.
- Hübscher, SG (2001) Recurrent autoimmune hepatitis after liver transplantation: diagnostic criteria, risk factors and outcome. Liver Transpl 4, 285–291.
- Gonzalez-Koch, A, Czaja AJ, Carpenter, HA et al. (2001) Recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver Transpl 7, 302–310.
- Molmenti EP, Netto GJ, Murray NG et al. (2002) Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients. Liver Transpl 8, 519–526.
- Vogel A, Heinrich E, Bahr MJ et al. (2004) Long-term outcome of liver transplantation for autoimmune hepatitis. Clin Transplant 18, 62–69.
- Prados E, Cuervas-Mons, V, De la Mata, M et al. (1998) Outcome of autoimmune hepatitis after liver transplantation. Transplantation 66, 1645–1650.
- Czaja AJ (2002) Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance. Liver Transpl 8, 505–513.
- Duclos-Vallée, J-C, Sebagh M, Rifai, K et al. (2003) A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence. Gut 52, 893–897.
- Kerkar N, Dugan C, Rumbo C et al. (2005) Rapamycin successfully treats post-transplant autoimmune hepatitis. Am J Transpl 5, 1085–1089.
- Bravata DM, Plkin I, Barnato AE et al. (2001) Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: a systematic review. Liver Transpl 7, 191–203.
- Tome S, Lucey MR (2003) Timing of liver transplantation in alcoholic cirrhosis. J Hepatol 39, 302–307.
- Jauhar S, Talwalkar JA, Schneekloth T et al. (2004) Analysis of factors that predict alcohol relapse following liver transplantation. Liver Transpl 10, 408–411.
- Gish RG, Lee A, Brooks, L et al. (2001) Long-term follow-up of patients diagnosed with alcohol dependence or alcohol abuse who were evaluated for liver transplantation. Liver Transpl 7, 581–587.
- Perney P, Bismuth M, Sigaud H et al. (2005) Are preoperative patterns of alcohol consumption predictive of relapse after liver transplantation for alcoholic liver disease? Transpl Int 18, 1292–1297.
- Beresford TP (1997) Predictive factors for alcoholic relapse in the selection of alcohol-dependent persons for hepatic transplant. Liver Transpl Surg 3, 280–291.
- Burra P, Mioni D, Cecchetto A et al. (2001) Histological features after liver transplantation in alcoholic cirrhotics. J Hepatol 34, 716–722.
- Pageaux G-P, Bismuth M, Perney, P et al. (2003) Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter? J Hepatol 38, 629–634.
- Cuadrado A, Fabrega E, Casafont F et al. (2005) Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl 11, 420–426.
- Contos MJ, Cales W, Sterling RK et al. (2001) Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl 7, 363–373.
- Ong J, Younossi ZM, Reddy V et al. (2001) Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease. Liver Transpl 7, 797–801.
- Bahr MJ, Schubert J, Bleck JS et al. (2003) Recurrence of Budd-Chiari syndrome after liver transplantation in paroxysmal nocturnal hemoglobinuria. Transpl Int 16, 890–894.
- Crawford DH, Fletcher LM, Hubscher SG et al. (2004) Patient and graft survival after liver transplantation for hereditary hemochromatosis: implications for pathogenesis. Hepatology 39, 1655–1662.
